epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Emgality (galcanezumab-gnlm)

galcanezumab

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  INJ (pen): 120 mg per injection; INJ (pre-filled syringe): 100 mg per mL, 120 mg per mL

Special Note

[drug name clarification]
Info: nonproprietary name = galcanezumab-gnlm

migraine prophylaxis

[120 mg SC qmo]
Start: 240 mg SC x1

cluster headache, episodic

[300 mg SC qmo]
Start: 300 mg SC x1 at onset of cluster period; Info: continue tx until end of cluster period

renal dosing

[see below]
mild-moderate impairment: no adjustment; severe impairment: not defined
HD/PD: not defined

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@63e75b24
  • hypersensitivity to drug or ingredient
  • caution: HTN
  • caution: Raynaud phenomenon

Drug Interactions .

Overview

galcanezumab

CGRP antagonist

Interaction Characteristics:
  • hypertensive effects

Avoid/Use Alternative

  • atogepant
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    atogepant
    1 interaction

    Avoid/Use Alternative

    galcanezumab + atogepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • epinephrine inhaled
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    galcanezumab + epinephrine inhaled

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • eptinezumab
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    eptinezumab
    1 interaction

    Avoid/Use Alternative

    galcanezumab + eptinezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • erenumab
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    erenumab
    1 interaction

    Avoid/Use Alternative

    galcanezumab + erenumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • fremanezumab
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fremanezumab
    1 interaction

    Avoid/Use Alternative

    galcanezumab + fremanezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • furosemide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    galcanezumab + furosemide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • galcanezumab
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    galcanezumab
    1 interaction

    Avoid/Use Alternative

    galcanezumab + galcanezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • midodrine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    galcanezumab + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • rimegepant
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    rimegepant
    1 interaction

    Avoid/Use Alternative

    galcanezumab + rimegepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • ubrogepant
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ubrogepant
    1 interaction

    Avoid/Use Alternative

    galcanezumab + ubrogepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • zavegepant
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    zavegepant
    1 interaction

    Avoid/Use Alternative

    galcanezumab + zavegepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

  • abiraterone acetate
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    galcanezumab + abiraterone acetate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • acebutolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • albuterol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + albuterol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • albuterol inhaled
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    galcanezumab + albuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aliskiren
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    galcanezumab + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • amiloride
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    galcanezumab + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amlodipine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphetamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + amphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • angiotensin II
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    galcanezumab + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aprocitentan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    galcanezumab + arformoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • armodafinil
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    galcanezumab + armodafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • asciminib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atenolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atomoxetine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + atomoxetine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine ophthalmic
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    galcanezumab + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • axitinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    galcanezumab + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benazepril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + benzphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betamethasone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + betamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betaxolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    galcanezumab + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bismuth subsalicylate
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    galcanezumab + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + bisoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • brigatinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • budesonide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + budesonide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bumetanide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + bumetanide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bupropion
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    galcanezumab + bupropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cabozantinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + caffeine

    monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

  • caffeine citrate
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    galcanezumab + caffeine citrate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • candesartan cilexetil
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    galcanezumab + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    galcanezumab + cannabis

    monitor BP: combo may incr. risk of HTN (additive effects)

  • captopril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carfilzomib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + carfilzomib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • carvedilol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • celecoxib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • chlorothiazide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + chlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chlorthalidone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + chlorthalidone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clevidipine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clonidine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cocaine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + cocaine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • copanlisib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + corticotropin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cortisone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + cortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cyclosporine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + cyclosporine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • danazol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + danazol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • darbepoetin alfa
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    galcanezumab + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • deflazacort
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    galcanezumab + deflazacort

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desmopressin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + desmopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desvenlafaxine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + desvenlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexamethasone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + dexamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexmethylphenidate
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    galcanezumab + dexmethylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dextroamphetamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + dextroamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    galcanezumab + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    galcanezumab + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diethylpropion
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    galcanezumab + diethylpropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diflunisal
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    galcanezumab + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dihydroergotamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + dihydroergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • diltiazem
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    galcanezumab + diltiazem

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dobutamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + dobutamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dopamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + dopamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxapram
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    galcanezumab + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dronabinol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + dronabinol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • droxidopa
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    galcanezumab + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • eletriptan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • enalapril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    galcanezumab + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedra
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ephedra

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine injection
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ephedrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine oral
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ephedrine oral

    monitor BP: combo may incr. risk of HTN (additive effects)

  • epinephrine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + epinephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eplerenone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    galcanezumab + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • esketamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    galcanezumab + estetrol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estradiol (contraceptive)
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    galcanezumab + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ethacrynic acid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethanol (alcoholic beverage)
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (contraceptive)
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    galcanezumab + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    galcanezumab + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • felodipine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + fenfluramine

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fenoldopam
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    galcanezumab + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    galcanezumab + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    galcanezumab + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fludrocortisone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + fludrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flurbiprofen
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    galcanezumab + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • formoterol inhaled
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    galcanezumab + formoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fosinopril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + fruquintinib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • guanfacine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hoodia
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    galcanezumab + hoodia

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydralazine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + hydrochlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrocortisone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + hydrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydroxocobalamin IV
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    galcanezumab + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibrutinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ibrutinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibuprofen
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • indapamide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + indapamide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • indomethacin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • irbesartan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isradipine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketoprofen
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • labetalol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • leflunomide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenvatinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levalbuterol inhaled
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    galcanezumab + levalbuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levomilnacipran
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    galcanezumab + levomilnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • licorice
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    galcanezumab + licorice

    monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects)

  • lisdexamfetamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + lisdexamfetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lisinopril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lorlatinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + lorlatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • losartan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lumacaftor/ivacaftor
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    galcanezumab + lumacaftor/ ivacaftor

    monitor BP: combo may incr. risk of HTN (additive effects)

  • luspatercept
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    galcanezumab + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium salicylate
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    galcanezumab + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • meclofenamate
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    galcanezumab + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    galcanezumab + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    galcanezumab + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methamphetamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + methamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    galcanezumab + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyldopa
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    galcanezumab + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + methylergonovine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • methylphenidate
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    galcanezumab + methylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methylprednisolone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + methylprednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metoclopramide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + metolazone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoprolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • milnacipran
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    galcanezumab + milnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • minoxidil
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    galcanezumab + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    galcanezumab + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • modafinil
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    galcanezumab + modafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • moexipril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nabumetone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nadolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    galcanezumab + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naratriptan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naxitamab
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    galcanezumab + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicardipine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nifedipine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nimodipine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • norepinephrine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • obinutuzumab
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    galcanezumab + obinutuzumab

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    galcanezumab + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    galcanezumab + olodaterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • osilodrostat
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    galcanezumab + osilodrostat

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxaprozin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    galcanezumab + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ozanimod

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • pazopanib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + pexidartinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phendimetrazine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phendimetrazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenoxybenzamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phentermine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phentolamine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phenylephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine injection
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN (additive effects)

  • phenylephrine rectal
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    galcanezumab + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pindolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • piroxicam
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    galcanezumab + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponatinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ponatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponesimod
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pralsetinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prazosin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + prednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prednisone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + prednisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • propranolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pseudoephedrine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + pseudoephedrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • quetiapine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + quetiapine

    monitor BP, especially in pts <18 yo: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramipril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ramucirumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • regorafenib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + regorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rizatriptan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ropinirole
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rotigotine transdermal
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    galcanezumab + rotigotine transdermal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • salmeterol inhaled
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    galcanezumab + salmeterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • salsalate
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    galcanezumab + salsalate

    monitor BP w/ high-dose salsalate: combo may incr. risk of HTN (additive effects)

  • selpercatinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • siponimod
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    galcanezumab + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • solriamfetol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + solriamfetol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sorafenib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • spironolactone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sulindac
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    galcanezumab + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sumatriptan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    galcanezumab + tacrolimus

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tagraxofusp
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    galcanezumab + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terazosin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    galcanezumab + terbutaline

    monitor BP: combo may incr. risk of HTN (additive effects)

  • teriflunomide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • timolol
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    galcanezumab + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tivozanib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolmetin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • torsemide
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    galcanezumab + torsemide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trametinib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    galcanezumab + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamcinolone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + triamcinolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • triamterene
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    galcanezumab + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vadadustat
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    galcanezumab + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    galcanezumab + vamorolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vandetanib
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    galcanezumab + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • venlafaxine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + venlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    galcanezumab + verapamil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vilanterol inhaled
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    galcanezumab + vilanterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • viloxazine
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    galcanezumab + viloxazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • voclosporin
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    galcanezumab + voclosporin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • yohimbe
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    galcanezumab + yohimbe

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    galcanezumab + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zolmitriptan
  • Emgality (galcanezumab-gnlm) (galcanezumab)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    galcanezumab + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@52b2d0a6
  • hypersensitivity reaction
  • anaphylaxis
  • HTN
  • Raynaud phenomenon

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@4d6f24d8
  • injection site reaction
  • hypersensitivity reaction
  • rash
  • urticaria
  • dyspnea

Safety/Monitoring .

Monitoring Parameters
BP

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; no human data available; no known risk of fetal harm based on animal data at 18-64x recommended human dose

Pregnancy Registry

enroll patients or encourage patients to enroll in Migraine Pregnancy Registry at 1-833-464-4724 or www.migrainepregnancyregistry.com

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@61a67e26

Metabolism: for galcanezumab: unknown; CYP450: none

Excretion: for galcanezumab: unknown; Half-life: 27 days

Subclass: CGRP Inhibitors ; Headache/Migraine

Mechanism of Action
for galcanezumab: blocks calcitonin gene-related peptide (CGRP) activity (monoclonal antibody)

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Eli Lilly and Co.

com.epocrates.rxweb.beans.DrugOtherInfoBean@202547e7

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

subcutaneous solution:

  • 120 mg/mL (1 pen): $650.00

subcutaneous solution:

  • 100 mg/mL (3 syringe): $1,610.00
  • 120 mg/mL (1 syringe): $650.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information